...
首页> 外文期刊>Journal of Hainan Medical University >Effects of methotrexate combined with hydroxychloroquine sulfate and prednisone acetate on inflammatory response, immune function and liver and renal function in patients with systemic lupus erythematosus
【24h】

Effects of methotrexate combined with hydroxychloroquine sulfate and prednisone acetate on inflammatory response, immune function and liver and renal function in patients with systemic lupus erythematosus

机译:甲氨蝶呤联合硫酸羟氯喹和醋酸泼尼松对系统性红斑狼疮患者炎症反应,免疫功能以及肝肾功能的影响

获取原文
           

摘要

Objective: To investigate the effects of methotrexate and hydroxychloroquine sulfate andprednisone on inflammatory response, immune function, liver and renal function in patientswith systemic lupus erythematosus (SLE). Methods: A total of 80 cases of SLE patientsaccording to the random data table were divided into the control group (n=40) and observationgroup (n=40), the control group were treated with hydroxychloroquine sulfate and prednisonetreatment, on the basis of treatment of the control group, patients in the observation group inthe control group were treated with methotrexate, the levels of inflammatory factors, immunefunction, liver and kidney function indexes in the two groups between the before treatmentand after treatment were compared. Results: Comparison of the levels before treatment, thedifference of the CRP, WBC, ESR, IgA, IgG, complement C3, complement C4, ALT, AST,SCr and BUN levels were not statistically significant. After treatment, the levels of CRP, ESR,IgA, IgG, ALT, AST, SCr and BUN in the observation group were significantly lower thanthose in the control group, and the difference was statistically significant. The levels of WBCand complement C4 in the observation group [(5.18±1.08)伊109 /L, (0.22±0.05) g/L] weresignificantly higher than those in the control group [(4.51±0.52)伊109 /L, (0.18±0.03) g/L],and there was no significant difference in the level of complement C3 between the two groupsafter treatment. Conclusion: Methotrexate combined with hydroxychloroquine sulfate andprednisone for the treatment of SLE can effectively reduce inflammation, improve immunefunction, has little effect on kidney function, high safety, which has an important clinical value.
机译:目的:探讨氨甲蝶呤和硫酸羟氯喹和泼尼松对系统性红斑狼疮(SLE)患者炎症反应,免疫功能,肝肾功能的影响。方法:将80例SLE患者按照随机数据表分为对照组(n = 40)和观察组(n = 40),对照组在治疗的基础上给予硫酸羟氯喹和泼尼松治疗在对照组中,对照组的观察组患者接受甲氨蝶呤治疗,比较两组治疗前后的炎症因子水平,免疫功能,肝肾功能指标。结果:治疗前的水平比较,CRP,WBC,ESR,IgA,IgG,补体C3,补体C4,ALT,AST,SCr和BUN的差异无统计学意义。治疗后,观察组的CRP,ESR,IgA,IgG,ALT,AST,SCr和BUN水平明显低于对照组,差异有统计学意义。观察组[(5.18±1.08)伊109 /L,(0.22±0.05)g / L]的白细胞和补体C4水平显着高于对照组[(4.51±0.52)伊109 / L,( 0.18±0.03)g / L],两组治疗后补体C3水平无明显差异。结论:甲氨蝶呤联合硫酸羟氯喹和泼尼松治疗SLE可有效减轻炎症,提高免疫功能,对肾功能影响不大,安全性高,具有重要的临床价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号